查看購物車
  • Simplified Chinese
  • English
捐捐血液成分市場規模及預測 2021-2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋：血液組成、適應症、應用、年齡層、最終用戶及地理
市場調查報告書
商品編碼
1780290

捐捐血液成分市場規模及預測 2021-2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋：血液組成、適應症、應用、年齡層、最終用戶及地理

Donor Blood Components Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component, Indication, Application, Age Group, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 342 Pages | 訂單完成後即時交付

價格

根據我們最新的研究報告《2031年捐捐血液成分市場預測－全球分析－按血液成分、適應症、應用、年齡層和地理分類》，預計該市場規模將從2024年的100.8億美元成長至2031年的146.4億美元；預計2025-2031年成長至2031年的146.4億美元；預計2025-2031年成長為5.7%。癌症和免疫抑制疾病盛行率的上升，以及捐贈意識的提高，都推動了捐血成分市場規模的成長。然而，自願捐獻的不穩定性阻礙了捐血成分市場的成長。此外，血漿衍生療法的需求不斷成長，預計將在未來幾年帶來新的捐捐血液成分市場趨勢。

捐捐血液成分市場是醫療保健產業的重要細分市場之一，其驅動力源於手術、創傷、癌症治療和慢性疾病期間對安全輸血日益成長的需求。捐捐血液成分包括紅血球 (RBC)、血漿、血小板和冷沉澱。全球意識的提升、人口老化以及採集和儲存技術的不斷進步，共同推動了捐捐血液成分市場的成長。然而，某些地區自願捐血率低、監管問題以及物流限制等問題仍然存在。血液分離和病原體去活化系統等新技術正在提高產品的安全性和效率。此外，政府和非政府組織為增加定期自願捐血而採取的措施也正在擴大捐血者群體。該市場潛力巨大，尤其是在不斷發展的醫療保健體系中。

捐捐血液成分市場分析

新興市場需求為未來提供市場機會

新興經濟體，尤其是東南亞、拉丁美洲和非洲部分地區的新興經濟體，為捐捐血液成分市場提供了強勁的成長機會。隨著這些經濟體醫療基礎設施的不斷發展，對捐血設施的投資正成為一項戰略要務。在阿根廷、巴西和墨西哥，自願捐血計畫取得了顯著進展：2023年，拉丁美洲共收到超過920萬單位血液，比2020年成長15.5%，其中56.8%的捐血來自移動募捐和線上宣傳活動。這一成長體現了宣傳活動和公私聯盟對國家血液系統的協同作用。同樣，例如在印度尼西亞，亞洲農業等企業捐助者發起了區域性捐血週活動，從農村省份累計捐贈了數百單位血液。 2024年6月，他們聯繫了414名捐血者，並從三個省份募集了287單位血液，為庫存補充和宣傳做出了貢獻。這些私部門的合作增強了社區信任和捐助者的參與。

根據世界衛生組織估計，發展中國家對血液製品的需求預計每年成長5%。為了滿足這項需求，這些國家正致力於基礎設施的現代化，例如印尼新建的血漿分離工廠，以及非洲增加的流動採血。血液分離設備、核酸檢測和自動化處理等技術的運用正在增強血液製品的安全性和公眾信任度。

醫療需求成長、自願捐血人數增加、數位化推廣以及監管改革等因素的融合，為新興市場在捐血服務領域的成長奠定了基礎。這些系統的發展不僅滿足了日益成長的臨床需求，也促進了全球捐血成分市場的長期永續發展。

捐捐血液成分市場報告細分分析

有助於得出捐捐血液成分市場分析的關鍵部分是產品、設備類型、應用、年齡層、性別和最終用戶。

根據血液成分，捐捐血液成分市場可細分為紅血球、白血球、血小板、血漿及其他。紅血球在2024年佔據了最大的市場。

根據適應症，捐捐血液成分市場可分為免疫抑制和腫瘤治療兩大類。 2024年，免疫抑制領域佔據市場主導地位。

從應用角度來看，捐捐血液成分市場細分為貧血管理、血小板減少症治療、凝血病矯正、化療期間的支持性護理、手術及其他領域。貧血管理領域在2024年佔據了最大的市場。

依年齡層分類，捐捐血液成分市場分為成人和兒童兩類。 2024年，成人群體佔據市場主導地位。

根據最終用戶，捐贈血液成分市場可分為醫院、腫瘤中心、移植中心、門診手術中心和其他。 2024年，醫院市場佔據主導地位。

捐捐血液成分市場：競爭格局與關鍵發展

羅斯威爾帕克綜合癌症中心、米蘭綜合醫院、Vitalant、MD 安德森癌症中心、約翰霍普金斯醫院、皇家馬斯登醫院、古斯塔夫魯西、彼得麥卡勒姆癌症中心、塔塔紀念醫院、紀念斯隆凱特琳癌症中心是捐捐血液成分市場的主要營運公司。

在編寫捐贈血液成分市場報告時參考的主要和次要來源包括世界衛生組織 (WHO)、美國整形外科醫師協會、衛生資源與服務管理局、美國癌症協會、白血病和淋巴瘤協會、加拿大衛生部、國際癌症研究機構 (IARC)、聯邦統計局 (Destatis)、麥克米倫癌症支持資料、國家衛生委員會 (NHC)、印度醫學研究理事會-國家疾病醫學和研究中心(ICMR-NCDIR)、澳洲健康與福利研究所、澳洲紅十字會生命血液、GLOBOCAN 等。

目錄

第1章：簡介

第2章：執行摘要

  • 分析師市場展望

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：
  • 假設和局限性

第4章：捐捐血液成分市場概況

  • 概述
  • PEST分析
  • 2024年血液成分每單位平均售價（美元）
  • 2024年全球五種主要疾病的盛行率

第5章：捐捐血液成分市場－關鍵市場動態

  • 捐捐血液成分市場－關鍵市場動態
  • 市場促進因素
    • 癌症和免疫抑制疾病發生率上升
    • 提高捐助者意識
  • 市場限制
    • 自願捐款不一致
  • 市場機會
    • 新興市場需求
  • 未來趨勢
    • 血漿衍生療法的需求不斷成長
  • 促進因素和限制因素的影響：

第6章：捐捐血液成分市場－全球市場分析

  • 2021-2031年捐血成分市場收入
  • 捐捐血液成分市場預測分析

第7章：捐捐血液成分市場分析－依血液成分

  • 紅血球
  • 白血球
  • 血小板
  • 電漿
  • 其他

第 8 章：捐捐血液成分市場分析 - 按適應症

  • 免疫抑制
  • 腫瘤學

第9章：捐捐血液成分市場分析－按應用

  • 貧血管理
  • 血小板減少症治療
  • 凝血病矯正
  • 化療期間的支持性治療
  • 手術
  • 其他

第10章：捐捐血液成分市場分析－依年齡層

  • 成人
  • 孩子

第 11 章：捐捐血液成分市場分析 - 依最終用戶

  • 醫院
  • 腫瘤中心
  • 移植中心
  • 門診手術中心
  • 其他

第 12 章：捐捐血液成分市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第13章：產業格局

  • 概述
  • 捐捐血液成分市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 14 章：公司簡介

  • Roswell Park Comprehensive Cancer Center
  • Policlinico of Milan
  • Vitalant
  • MD Anderson Cancer Center.
  • The Johns Hopkins Hospital
  • The Royal Marsden
  • Gustave Roussy
  • Peter MacCallum Cancer Centre
  • Tata Memorial Hospital
  • Memorial Sloan Kettering Cancer Center

第 15 章：附錄

Product Code: TIPRE00040976

According to our new research study on "Donor Blood Component Market Forecast to 2031 -Global Analysis - by Blood Component, Indication, Application, Age Group, and Geography," the market is anticipated to grow from US$ 10.08 billion in 2024 and is projected to reach US$ 14.64 billion by 2031; it is expected to register a CAGR of 5.7% during 2025-2031. Rising prevalence of cancer and immunosuppressive diseases, and increasing donor awareness are contributing to the growing donor blood component market size. However, the inconsistent voluntary donations hamper the donor blood component market growth. Further, rising demand for plasma-derived therapies are expected to bring in new donor blood component market trends in the coming years.

The donor blood components market is one of the prominent segments of the healthcare industry, driven by the increasing need for safe transfusions during surgery, trauma, cancer treatment, and chronic disease. Donor blood components include red blood cells (RBCs), plasma, platelets, and cryoprecipitate. The donor blood components market growth is being propelled by rising global awareness, aging populations, and growing advancements in collection and storage technologies. However, issues such as low rates of voluntary donations in certain regions, regulatory issues, and logistical limitations remain. New technologies such as apheresis and pathogen reduction systems are improving product safety and efficiency. Furthermore, government and NGO initiatives to increase regular, voluntary blood donation are increasing the donor base. The market has great potential, particularly in evolving healthcare systems.

Donor Blood Component Market Analysis

Emerging Market Demand to Provide Market Opportunities in Future

Emerging economies, particularly in Southeast Asia, Latin America, and some regions in Africa, offer a strong growth opportunity for the donor blood component market. As healthcare infrastructure in these economies grows, investment in blood donation facilities is emerging as a strategic imperative. In Argentina, Brazil, and Mexico, voluntary donations voluntary donation programs have gained significant traction: Latin America received more than 9.2 million units in 2023, a 15.5% increase over 2020, with 56.8% of donations voluntary due to mobile drives and online campaigns. This growth represents the collaborative coordination of awareness campaigns and public-private alliances that have had on national blood systems. Similarly, in Indonesia, for instance, corporate donors such as Asian Agri initiated regional Blood Donation Weeks, accumulating hundreds of units from rural provinces. In June 2024, they engaged 414 donors and collected 287 units from three provinces, contributing to inventory and awareness. These private-sector cooperation enhances community trust and donor participation.

According to the WHO, the demand for blood products is projected to increase 5% each year in developing nations. To respond to the demand, the nations are focusing on the modernization of infrastructure, such as Indonesia's new plasma-fractionation factory and increased mobile blood collections in Africa. Technological utilization in the form of apheresis equipment, NAT testing, and automation processing is enhancing safety and public trust.

The convergence of growing medical demand, increasing voluntary donation, digital outreach, and regulatory reforms positions emerging markets for growth in donor blood services. Developments in these systems not only meet increasing clinical need but also catalyze long-term sustainability in the global donor blood component market.

Donor Blood Component Market Report Segmentation Analysis

Key segments that contributed to the derivation of the donor blood component market analysis are product, device type, application, age group, gender, and end user.

Based on blood component, the donor blood components market is segmented into red blood cells, white blood cells, platelets, plasma, and others. The red blood cells segment held the largest share of the market in 2024.

By indication, the donor blood components market is bifurcated into immunosuppression and oncology. The immunosuppression segment dominated the market in 2024.

In terms of application, the donor blood components market is segmented into anemia management, thrombocytopenia treatment, coagulopathy correction, supportive care during chemotherapy, surgery, and others. The anemia management segment held the largest share of the market in 2024.

By age group, the donor blood components market is bifurcated into adult and child. The adult segment dominated the market in 2024.

As per end user, the donor blood components market is categorized into hospitals, oncology centers, transplant centers, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2024.

Donor Blood Component Market: Competitive Landscape and Key Developments

Roswell Park Comprehensive Cancer Center, Policlinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center are among the key companies operating in the donor blood component market.

The World Health Organization (WHO), the American Society of Plastic Surgeons, Health Resources and Services Administration, American Cancer Society, The Leukemia & Lymphoma Society, Health Canada, International Agency for Research on Cancer (IARC), Federal Statistical Office (Destatis), Macmillan Cancer Support data, National Health Commission (NHC), Indian Council of Medical Research-National Centre for Disease Informatics and Research (ICMR-NCDIR), Australian Institute of Health and Welfare, Australian Red Cross Lifeblood, GLOBOCAN are among the primary and secondary sources referred to while preparing the donor blood components market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Donor Blood Component Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
  • 4.4 Global Disease Prevalence of 5 Key Diseases, 2024

5. Donor Blood Component Market - Key Market Dynamics

  • 5.1 Donor Blood Component Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Cancer and Immunosuppressive Diseases
    • 5.2.2 Increasing Donor Awareness
  • 5.3 Market Restraints
    • 5.3.1 Inconsistent Voluntary Donations
  • 5.4 Market Opportunities
    • 5.4.1 Emerging Market Demand
  • 5.5 Future Trends
    • 5.5.1 Rising Demand for Plasma-Derived Therapies
  • 5.6 Impact of Drivers and Restraints:

6. Donor Blood Component Market - Global Market Analysis

  • 6.1 Donor Blood Component Market Revenue (US$ Million), 2021-2031
  • 6.2 Donor Blood Component Market Forecast Analysis

7. Donor Blood Component Market Analysis - by Blood Component

  • 7.1 Red Blood Cells
    • 7.1.1 Overview
    • 7.1.2 Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 White blood cells
    • 7.2.1 Overview
    • 7.2.2 White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Platelets
    • 7.3.1 Overview
    • 7.3.2 Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Plasma
    • 7.4.1 Overview
    • 7.4.2 Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

8. Donor Blood Component Market Analysis - by Indication

  • 8.1 Immunosuppression
    • 8.1.1 Overview
    • 8.1.2 Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Oncology
    • 8.2.1 Overview
    • 8.2.2 Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

9. Donor Blood Component Market Analysis - by Application

  • 9.1 Anemia management
    • 9.1.1 Overview
    • 9.1.2 Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Thrombocytopenia treatment
    • 9.2.1 Overview
    • 9.2.2 Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Coagulopathy Correction
    • 9.3.1 Overview
    • 9.3.2 Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Supportive care during chemotherapy
    • 9.4.1 Overview
    • 9.4.2 Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Surgery
    • 9.5.1 Overview
    • 9.5.2 Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

10. Donor Blood Component Market Analysis - by Age Group

  • 10.1 Adult
    • 10.1.1 Overview
    • 10.1.2 Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Child
    • 10.2.1 Overview
    • 10.2.2 Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

11. Donor Blood Component Market Analysis - by End User

  • 11.1 Hospitals
    • 11.1.1 Overview
    • 11.1.2 Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Oncology centers
    • 11.2.1 Overview
    • 11.2.2 Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Transplant centers
    • 11.3.1 Overview
    • 11.3.2 Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Ambulatory surgical centers
    • 11.4.1 Overview
    • 11.4.2 Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

12. Donor Blood Component Market - Geographical Analysis

  • 12.1 North America
    • 12.1.1 North America Donor Blood Component Market Overview
    • 12.1.2 North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
      • 12.1.2.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
      • 12.1.2.2 North America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
      • 12.1.2.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
        • 12.1.2.3.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
        • 12.1.2.3.2 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
      • 12.1.2.4 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
      • 12.1.2.5 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
      • 12.1.2.6 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
    • 12.1.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.3.1.1 United States: Donor Blood Component Market Breakdown, by Blood Component
        • 12.1.3.1.2 United States: Donor Blood Component Market Breakdown, by Blood Component
        • 12.1.3.1.3 United States: Donor Blood Component Market Breakdown, by Indication
          • 12.1.3.1.3.1 United States: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.1.3.1.3.2 United States: Donor Blood Component Market Breakdown, by Oncology
        • 12.1.3.1.4 United States: Donor Blood Component Market Breakdown, by Application
        • 12.1.3.1.5 United States: Donor Blood Component Market Breakdown, by Age Group
        • 12.1.3.1.6 United States: Donor Blood Component Market Breakdown, by End User
      • 12.1.3.2 Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.3.2.1 Canada: Donor Blood Component Market Breakdown, by Blood Component
        • 12.1.3.2.2 Canada: Donor Blood Component Market Breakdown, by Blood Component
        • 12.1.3.2.3 Canada: Donor Blood Component Market Breakdown, by Indication
          • 12.1.3.2.3.1 Canada: Donor Blood Component Market Breakdown,
          • 12.1.3.2.3.2 Canada: Donor Blood Component Market Breakdown, by Oncology
        • 12.1.3.2.4 Canada: Donor Blood Component Market Breakdown, by Application
        • 12.1.3.2.5 Canada: Donor Blood Component Market Breakdown, by Age Group
        • 12.1.3.2.6 Canada: Donor Blood Component Market Breakdown, by End User
      • 12.1.3.3 Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Blood Component
        • 12.1.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Blood Component
        • 12.1.3.3.3 Mexico: Donor Blood Component Market Breakdown, by Indication
          • 12.1.3.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.1.3.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Oncology
        • 12.1.3.3.4 Mexico: Donor Blood Component Market Breakdown, by Application
        • 12.1.3.3.5 Mexico: Donor Blood Component Market Breakdown, by Age Group
        • 12.1.3.3.6 Mexico: Donor Blood Component Market Breakdown, by End User
  • 12.2 Europe
    • 12.2.1 Europe Donor Blood Component Market Overview
    • 12.2.2 Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
      • 12.2.2.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
      • 12.2.2.2 Europe: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
      • 12.2.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
        • 12.2.2.3.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
        • 12.2.2.3.2 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
      • 12.2.2.4 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
      • 12.2.2.5 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
      • 12.2.2.6 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
    • 12.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
      • 12.2.3.1 Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.1.1 Germany: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.1.2 Germany: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.1.3 Germany: Donor Blood Component Market Breakdown, by Indication
          • 12.2.3.1.3.1 Germany: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.2.3.1.3.2 Germany: Donor Blood Component Market Breakdown, by Oncology
        • 12.2.3.1.4 Germany: Donor Blood Component Market Breakdown, by Application
        • 12.2.3.1.5 Germany: Donor Blood Component Market Breakdown, by Age Group
        • 12.2.3.1.6 Germany: Donor Blood Component Market Breakdown, by End User
      • 12.2.3.2 United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.2.1 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.2.2 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.2.3 United Kingdom: Donor Blood Component Market Breakdown, by Indication
          • 12.2.3.2.3.1 United Kingdom: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.2.3.2.3.2 United Kingdom: Donor Blood Component Market Breakdown, by Oncology
        • 12.2.3.2.4 United Kingdom: Donor Blood Component Market Breakdown, by Application
        • 12.2.3.2.5 United Kingdom: Donor Blood Component Market Breakdown, by Age Group
        • 12.2.3.2.6 United Kingdom: Donor Blood Component Market Breakdown, by End User
      • 12.2.3.3 France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.3.1 France: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.3.2 France: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.3.3 France: Donor Blood Component Market Breakdown, by Indication
          • 12.2.3.3.3.1 France: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.2.3.3.3.2 France: Donor Blood Component Market Breakdown, by Oncology
        • 12.2.3.3.4 France: Donor Blood Component Market Breakdown, by Application
        • 12.2.3.3.5 France: Donor Blood Component Market Breakdown, by Age Group
        • 12.2.3.3.6 France: Donor Blood Component Market Breakdown, by End User
      • 12.2.3.4 Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.4.1 Spain: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.4.2 Spain: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.4.3 Spain: Donor Blood Component Market Breakdown, by Indication
          • 12.2.3.4.3.1 Spain: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.2.3.4.3.2 Spain: Donor Blood Component Market Breakdown, by Oncology
        • 12.2.3.4.4 Spain: Donor Blood Component Market Breakdown, by Application
        • 12.2.3.4.5 Spain: Donor Blood Component Market Breakdown, by Age Group
        • 12.2.3.4.6 Spain: Donor Blood Component Market Breakdown, by End User
      • 12.2.3.5 Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.5.1 Italy: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.5.2 Italy: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.5.3 Italy: Donor Blood Component Market Breakdown, by Indication
          • 12.2.3.5.3.1 Italy: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.2.3.5.3.2 Italy: Donor Blood Component Market Breakdown, by Oncology
        • 12.2.3.5.4 Italy: Donor Blood Component Market Breakdown, by Application
        • 12.2.3.5.5 Italy: Donor Blood Component Market Breakdown, by Age Group
        • 12.2.3.5.6 Italy: Donor Blood Component Market Breakdown, by End User
      • 12.2.3.6 Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.6.1 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.6.2 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
        • 12.2.3.6.3 Rest of Europe: Donor Blood Component Market Breakdown, by Indication
          • 12.2.3.6.3.1 Rest of Europe: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.2.3.6.3.2 Rest of Europe: Donor Blood Component Market Breakdown, by Oncology
        • 12.2.3.6.4 Rest of Europe: Donor Blood Component Market Breakdown, by Application
        • 12.2.3.6.5 Rest of Europe: Donor Blood Component Market Breakdown, by Age Group
        • 12.2.3.6.6 Rest of Europe: Donor Blood Component Market Breakdown, by End User
  • 12.3 Asia Pacific
    • 12.3.1 Asia Pacific Donor Blood Component Market Overview
    • 12.3.2 Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
      • 12.3.2.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
      • 12.3.2.2 Asia Pacific: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
      • 12.3.2.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
        • 12.3.2.3.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
        • 12.3.2.3.2 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
      • 12.3.2.4 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
      • 12.3.2.5 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
      • 12.3.2.6 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
    • 12.3.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
      • 12.3.3.1 China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.1.1 China: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.1.2 China: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.1.3 China: Donor Blood Component Market Breakdown, by Indication
          • 12.3.3.1.3.1 China: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.3.3.1.3.2 China: Donor Blood Component Market Breakdown, by Oncology
        • 12.3.3.1.4 China: Donor Blood Component Market Breakdown, by Application
        • 12.3.3.1.5 China: Donor Blood Component Market Breakdown, by Age Group
        • 12.3.3.1.6 China: Donor Blood Component Market Breakdown, by End User
      • 12.3.3.2 Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.2.1 Japan: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.2.2 Japan: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.2.3 Japan: Donor Blood Component Market Breakdown, by Indication
          • 12.3.3.2.3.1 Japan: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.3.3.2.3.2 Japan: Donor Blood Component Market Breakdown, by Oncology
        • 12.3.3.2.4 Japan: Donor Blood Component Market Breakdown, by Application
        • 12.3.3.2.5 Japan: Donor Blood Component Market Breakdown, by Age Group
        • 12.3.3.2.6 Japan: Donor Blood Component Market Breakdown, by End User
      • 12.3.3.3 India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.3.1 India: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.3.2 India: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.3.3 India: Donor Blood Component Market Breakdown, by Indication
          • 12.3.3.3.3.1 India: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.3.3.3.3.2 India: Donor Blood Component Market Breakdown, by Oncology
        • 12.3.3.3.4 India: Donor Blood Component Market Breakdown, by Application
        • 12.3.3.3.5 India: Donor Blood Component Market Breakdown, by Age Group
        • 12.3.3.3.6 India: Donor Blood Component Market Breakdown, by End User
      • 12.3.3.4 Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.4.1 Australia: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.4.2 Australia: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.4.3 Australia: Donor Blood Component Market Breakdown, by Indication
          • 12.3.3.4.3.1 Australia: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.3.3.4.3.2 Australia: Donor Blood Component Market Breakdown, by Oncology
        • 12.3.3.4.4 Australia: Donor Blood Component Market Breakdown, by Application
        • 12.3.3.4.5 Australia: Donor Blood Component Market Breakdown, by Age Group
        • 12.3.3.4.6 Australia: Donor Blood Component Market Breakdown, by End User
      • 12.3.3.5 South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.5.1 South Korea: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.5.2 South Korea: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.5.3 South Korea: Donor Blood Component Market Breakdown, by Indication
          • 12.3.3.5.3.1 South Korea: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.3.3.5.3.2 South Korea: Donor Blood Component Market Breakdown, by Oncology
        • 12.3.3.5.4 South Korea: Donor Blood Component Market Breakdown, by Application
        • 12.3.3.5.5 South Korea: Donor Blood Component Market Breakdown, by Age Group
        • 12.3.3.5.6 South Korea: Donor Blood Component Market Breakdown, by End User
      • 12.3.3.6 Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.6.1 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.6.2 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
        • 12.3.3.6.3 Rest of APAC: Donor Blood Component Market Breakdown, by Indication
          • 12.3.3.6.3.1 Rest of APAC: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.3.3.6.3.2 Rest of APAC: Donor Blood Component Market Breakdown, by Oncology
        • 12.3.3.6.4 Rest of APAC: Donor Blood Component Market Breakdown, by Application
        • 12.3.3.6.5 Rest of APAC: Donor Blood Component Market Breakdown, by Age Group
        • 12.3.3.6.6 Rest of APAC: Donor Blood Component Market Breakdown, by End User
  • 12.4 Middle East and Africa
    • 12.4.1 Middle East and Africa Donor Blood Component Market Overview
    • 12.4.2 Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
      • 12.4.2.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
      • 12.4.2.2 Middle East and Africa: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
      • 12.4.2.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
        • 12.4.2.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
        • 12.4.2.3.2 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
      • 12.4.2.4 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
      • 12.4.2.5 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
      • 12.4.2.6 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
    • 12.4.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
      • 12.4.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
      • 12.4.3.2 Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.4.3.2.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
        • 12.4.3.2.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
        • 12.4.3.2.3 Saudi Arabia: Donor Blood Component Market Breakdown, by Indication
          • 12.4.3.2.3.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.4.3.2.3.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Oncology
        • 12.4.3.2.4 Saudi Arabia: Donor Blood Component Market Breakdown, by Application
        • 12.4.3.2.5 Saudi Arabia: Donor Blood Component Market Breakdown, by Age Group
        • 12.4.3.2.6 Saudi Arabia: Donor Blood Component Market Breakdown, by End User
      • 12.4.3.3 South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.4.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Blood Component
        • 12.4.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Blood Component
        • 12.4.3.3.3 South Africa: Donor Blood Component Market Breakdown, by Indication
          • 12.4.3.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.4.3.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Oncology
        • 12.4.3.3.4 South Africa: Donor Blood Component Market Breakdown, by Application
        • 12.4.3.3.5 South Africa: Donor Blood Component Market Breakdown, by Age Group
        • 12.4.3.3.6 South Africa: Donor Blood Component Market Breakdown, by End User
      • 12.4.3.4 United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.4.3.4.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
        • 12.4.3.4.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
        • 12.4.3.4.3 United Arab Emirates: Donor Blood Component Market Breakdown, by Indication
          • 12.4.3.4.3.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.4.3.4.3.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Oncology
        • 12.4.3.4.4 United Arab Emirates: Donor Blood Component Market Breakdown, by Application
        • 12.4.3.4.5 United Arab Emirates: Donor Blood Component Market Breakdown, by Age Group
        • 12.4.3.4.6 United Arab Emirates: Donor Blood Component Market Breakdown, by End User
      • 12.4.3.5 Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.4.3.5.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
        • 12.4.3.5.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
        • 12.4.3.5.3 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Indication
          • 12.4.3.5.3.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.4.3.5.3.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Oncology
        • 12.4.3.5.4 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Application
        • 12.4.3.5.5 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Age Group
        • 12.4.3.5.6 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by End User
  • 12.5 South and Central America
    • 12.5.1 South and Central America Donor Blood Component Market Overview
    • 12.5.2 South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
      • 12.5.2.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
      • 12.5.2.2 South and Central America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
      • 12.5.2.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
        • 12.5.2.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
        • 12.5.2.3.2 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
      • 12.5.2.4 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
      • 12.5.2.5 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
      • 12.5.2.6 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
    • 12.5.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
      • 12.5.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
      • 12.5.3.2 Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.5.3.2.1 Brazil: Donor Blood Component Market Breakdown, by Blood Component
        • 12.5.3.2.2 Brazil: Donor Blood Component Market Breakdown, by Blood Component
        • 12.5.3.2.3 Brazil: Donor Blood Component Market Breakdown, by Indication
          • 12.5.3.2.3.1 Brazil: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.5.3.2.3.2 Brazil: Donor Blood Component Market Breakdown, by Oncology
        • 12.5.3.2.4 Brazil: Donor Blood Component Market Breakdown, by Application
        • 12.5.3.2.5 Brazil: Donor Blood Component Market Breakdown, by Age Group
        • 12.5.3.2.6 Brazil: Donor Blood Component Market Breakdown, by End User
      • 12.5.3.3 Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.5.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Blood Component
        • 12.5.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Blood Component
        • 12.5.3.3.3 Argentina: Donor Blood Component Market Breakdown, by Indication
          • 12.5.3.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.5.3.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Oncology
        • 12.5.3.3.4 Argentina: Donor Blood Component Market Breakdown, by Application
        • 12.5.3.3.5 Argentina: Donor Blood Component Market Breakdown, by Age Group
        • 12.5.3.3.6 Argentina: Donor Blood Component Market Breakdown, by End User
      • 12.5.3.4 Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.5.3.4.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
        • 12.5.3.4.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
        • 12.5.3.4.3 Rest of South and Central America: Donor Blood Component Market Breakdown, by Indication
          • 12.5.3.4.3.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Immunosuppression
          • 12.5.3.4.3.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Oncology
        • 12.5.3.4.4 Rest of South and Central America: Donor Blood Component Market Breakdown, by Application
        • 12.5.3.4.5 Rest of South and Central America: Donor Blood Component Market Breakdown, by Age Group
        • 12.5.3.4.6 Rest of South and Central America: Donor Blood Component Market Breakdown, by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Donor Blood Component Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. COMPANY PROFILES

  • 14.1 Roswell Park Comprehensive Cancer Center
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Policlinico of Milan
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
  • 14.3 Vitalant
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 MD Anderson Cancer Center.
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
  • 14.5 The Johns Hopkins Hospital
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
  • 14.6 The Royal Marsden
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
  • 14.7 Gustave Roussy
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
  • 14.8 Peter MacCallum Cancer Centre
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
  • 14.9 Tata Memorial Hospital
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Memorial Sloan Kettering Cancer Center
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Donor Blood Component Market Segmentation
  • Table 2. Average Selling Price Per Unit (US$) of Blood Components, 2024
  • Table 3. Global Disease Prevalence of 5 Key Diseases, 2024
  • Table 4. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 5. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 6. Donor Blood Component Market - Volume, 2021-2024 (Units Million) - by Blood Component
  • Table 7. Donor Blood Component Market - Volume, 2021-2024 (Units Million) - by Blood Component
  • Table 8. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 9. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 10. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 11. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 12. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 13. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 14. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 17. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 18. North America: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 19. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 20. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 21. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 22. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 23. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 24. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 25. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 26. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 27. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 28. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 29. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 30. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 31. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 32. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 33. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 34. United States: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 35. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 36. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 37. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 38. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 39. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 40. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 41. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 42. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 43. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 44. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 45. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 46. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 47. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 48. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 49. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 50. Canada: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 51. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 52. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 53. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 54. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 55. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 56. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 57. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 58. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 59. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 61. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 62. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 63. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 64. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 65. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 66. Mexico: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 67. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 68. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 69. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 70. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 71. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 72. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 73. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 74. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 75. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 76. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 77. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 78. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 81. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 82. Europe: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 83. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 84. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 85. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 86. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 87. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 88. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 89. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 90. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 91. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 92. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 93. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 94. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 95. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 96. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 97. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 98. Germany: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 99. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 100. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 101. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 102. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 103. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 104. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 105. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 106. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 107. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 108. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 109. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 110. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 113. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 114. United Kingdom: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 115. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 116. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 117. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 118. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 119. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 120. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 121. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 122. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 123. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 124. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 125. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 126. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 127. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 128. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 129. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 130. France: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 131. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 132. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 133. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 134. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 135. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 136. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 137. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 138. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 139. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 140. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 141. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 142. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 143. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 144. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 145. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 146. Spain: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 147. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 148. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 149. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 150. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 151. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 152. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 153. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 154. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 155. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 156. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 157. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 158. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 159. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 160. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 161. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 162. Italy: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 163. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 164. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 165. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 166. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 167. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 168. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 169. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 170. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 171. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 172. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 173. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 174. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 175. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 176. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 177. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 178. Rest of Europe: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 179. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 180. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 181. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 182. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 183. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 184. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 185. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 186. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 187. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 188. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 189. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 190. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 191. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 192. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 193. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 194. Asia Pacific: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 195. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 196. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 197. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 198. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 199. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 200. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 201. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 202. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 203. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 204. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 205. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 206. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 207. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 208. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 209. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 210. China: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 211. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 212. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 213. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 214. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 215. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 216. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 217. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 218. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 219. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 220. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 221. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 222. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 223. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 224. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 225. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 226. Japan: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 227. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 228. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 229. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 230. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 231. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 232. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 233. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 234. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 235. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 236. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 237. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 238. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 239. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 240. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 241. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 242. India: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 243. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 244. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 245. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 246. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 247. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 248. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 249. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 250. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 251. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 252. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 253. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 254. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 255. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 256. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 257. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 258. Australia: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 259. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 260. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 261. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 262. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 263. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 264. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 265. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 266. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 267. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 268. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 269. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 270. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 271. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 272. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 273. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 274. South Korea: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 275. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 276. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 277. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 278. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 279. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 280. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 281. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 282. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 283. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 284. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 285. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 286. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 287. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 288. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 289. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 290. Rest of APAC: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 291. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 292. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 293. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 294. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
  • Table 295. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
  • Table 296. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
  • Table 297. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
  • Table 298. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 299. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 300. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
  • Table 301. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
  • Table 302. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 303. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 304. Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
  • Table 305. Middle East and Africa: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
  • Table 306. Middle East and Africa: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
  • Table 307. Middle East and Africa: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component

Table

List Of Figures

  • Figure 1. Donor Blood Component Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Donor Blood Component Market Revenue (US$ Million), 2021-2031
  • Figure 5. Donor Blood Component Market Share (%) - by Blood Component (2024 and 2031)
  • Figure 6. Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Donor Blood Component Market Share (%) - by Indication (2024 and 2031)
  • Figure 12. Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Donor Blood Component Market Share (%) - by Application (2024 and 2031)
  • Figure 15. Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Donor Blood Component Market Share (%) - by Age Group (2024 and 2031)
  • Figure 22. Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Donor Blood Component Market Share (%) - by End User (2024 and 2031)
  • Figure 25. Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  • Figure 31. North America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 32. United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  • Figure 36. Europe: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 37. Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 39. France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  • Figure 44. Asia Pacific: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 45. China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 49. South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 50. Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 51. Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  • Figure 52. Middle East and Africa: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 53. Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 56. Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  • Figure 58. South and Central America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 59. Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 60. Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 61. Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 62. Growth Strategies in the Donor Blood Component Market